Department of Medicine
Faculty Profiles by Division

Division of Pulmonary, Allergy and Critical Care Medicine

Faculty Profiles

[Return To Index page]
photo Belinda N Rivera-Lebron, MD, MSCE

Associate Professor of Medicine

Director, UPMC Acute Pulmonary Embolus (PE) Program

Director, UPMC Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program


Phone: 412-864-3199

Office: UPMC Montefiore Hospital, NW 628, Room S652.1
3459 Fifth Avenue
Pittsburgh, PA 15213
Phone: 412-864-3199
Fax: 412-692-2260
Administrative Assistant:
Judy Nauman
Phone: 412-864-3199
Fax: 412-692-2260
Education and Training
BS, University of Puerto Rico, 2002
MD, Universidad Central del Caribe, 2006
Masters in Science and Clinical Epidemiology (MSCE), University of Pennsylvania, 2012
Internship, Internal Medicine, Boston University Medical Center, 2007
Residency, Internal Medicine, Boston University Medical Center, 2009
Fellowship, Pulmonary and Critical Care, University of Pennsylvania, 2012
Clinical Interest
Dr. Rivera-Lebron’s clinical interests are primarily focused on the diagnosis, management and treatment of pulmonary hypertension. She is an attending physician in the Comprehensive Pulmonary Hypertension Program. She works with patients with all forms of pulmonary hypertension, including pulmonary arterial hypertension, pulmonary hypertension related to chronic lung disease (emphysema and pulmonary fibrosis), and pulmonary hypertension related to chronic blood clots (chronic thromboembolic pulmonary hypertension). Dr. Rivera-Lebron also specializes in acute and chronic pulmonary embolism. She also works as attending intensivist physician at Shadyside-UPMC.
For my complete bibliography, Click Here.
Selected Publications:
Rivera Lebron BN, Cruz Morel K, Risbano MG. Postural Changes from Ventilatory Gas Exchange in Pulmonary Hypertension: Is it a practical solution to a complex question?. Respirology. 2019; DOI: 10.1111/resp.13691.
Mehta M, Toma C, Cilia L, D'Auria S, Rivera-Lebron BN, Palevsky H, Matthai W, Khandhar S. Invasive Hemodynamic Assessment of Patients with Submassive Pulmonary Embolism. Catheter Cardiovasc Interv. 2019.
Singh A, Feingold B, Rivera-Lebron BN, Weiner D, Drant S. Correlating Objective Echocardiographic Parameters in Patients with Pulmonary Hypertension due to Bronchopulmonary Dysplasia. J Perinatol. 2019; Jul 16: doi:10.1038/s41372-019-0429-3.
Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C, Blais D, Janicke D, Melamed R, Mohrien K, Rozycki E, Ross CB, Klein AJ, Rali P, Teman NR, Yarboro L, Ichinose E, Sharma AM, Bartos JA, and the PERT Consortium. Diagnosis, Treatment and Follow-up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clin Appl Thromb Hemost. 2019; Jan-Dec;25: 1076029619853037.
Rosovsky R, Zhao K, Sista A, Rivera-Lebron BN, Kabhrel C. Pulmonary embolism response teams: Purpose, evidence for efficacy and future research directions. Res Pract Thromb Haemost. 2019; Jun9;3(3): 315-30.
Porres-Aguilar M, Anaya JE, Heresi GA, Rivera-Lebron BN. Pulmonary Embolism Response Teams: a Novel Approach for the Care of Complex Patients with Pulmonary Embolism. Clin Appl Thromb Hemost. 2018; Nov19: 1076029618812954.
Nguyen Q, Rivera-Lebron BN. Venous Thromboembolism in Special Populations: pre-existing cardiopulmonary disease, cirrhosis, ESRD, and asplenia. Clinics in Chest Med. 2018; Sept;39(3): 515-524.
Avgerinos ED, Saadeddin Z, Abou Ali AN, Fish L, Toma C, Chaer M, Rivera-Lebron BN, Chaer RA. Catheter-directed Thrombolysis for Acute Pulmonary Embolism: A Meta-analysis of Outcomes for High and Intermediate Risk PE, Standard and Ultrasound Assisted Techniques. J Vasc Surg Venous Lymphat Disord. 2018; Jul;6(4): 530-540.
Avgerinos ED, Abou Ali AN, Liang NL, Rivera-Lebron B, Toma C, Maholic R, Makaroun MS, Chaer RA. Catheter-directed interventions compared to systemic thrombolysis achieve improved ventricular function recovery at a potentially lower complication rate for acute PE. J Vasc Surg Venous Lymphat Disord. 2018; Jul;6(4): 425-432.
Groetzinger LM, Miller TJ, Rivosecchi RM, Smith RE, Gladwin MT, Rivera-Lebron BN. Apixaban or rivaroxaban versus warfarin for treatment of submassive pulmonary embolism after catheter directed thrombolysis. Clin Appl Thromb Hemost. 2018; Jan: DOI:10.1177/1076029618755311.